ELOCON

This brand name is authorized in United States. It is also authorized in Australia, Austria, Cyprus, Estonia, Finland, Germany, Ireland, Lithuania, Netherlands, New Zealand, South Africa, Turkey, UK.

Active ingredients

The drug ELOCON contains one active pharmaceutical ingredient (API):

1	Mometasone UNII 04201GDN4R - MOMETASONE FUROATE
	Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade.
	Read more about Mometasone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ELOCON Lotion, 0.1%	MPI, US: SPL/PLR	FDA, National Drug Code (US)
ELOCON Cream	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
ELOCON Cream, 0.1%	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07AC13	Mometasone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10791Y, 10792B, 10793C, 10804P, 10805Q, 10809X, 10812C, 10814E, 10815F, 10818J, 10819K, 10826T, 10827W, 10828X, 1913Q, 1915T, 4342M, 4343N, 8043H
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	07517031, 07517048, 07517054
EE	Ravimiamet	1028933, 1028944, 1028955, 1061952, 1061963, 1061985, 1807219, 1807220, 1836165, 1842094, 1847101
FI	Lääkealan turvallisuus- ja kehittämiskeskus	000448, 116160, 116327, 116400, 116418
GB	Medicines & Healthcare Products Regulatory Agency	138709, 138711, 138715, 142177, 142180, 142185, 161710, 161711, 161713, 161715, 21394, 21402, 21403, 21408, 21412, 381325, 381326
IE	Health Products Regulatory Authority	22882, 22907, 23440
LT	Valstybinė vaistų kontrolės tarnyba	1003000, 1003001, 1003003, 1088516, 1088517
NL	Z-Index G-Standaard	14068478, 14068486, 14068494
NL	Z-Index G-Standaard, PRK	46914, 63169, 63177
NZ	Medicines and Medical Devices Safety Authority	5957, 5958, 5959
TR	İlaç ve Tıbbi Cihaz Kurumu	8683280337114, 8683280337121, 8683280337138, 8699636350294, 8699636350300
US	FDA, National Drug Code	0085-0370, 0085-0854, 0085-3149
ZA	Health Products Regulatory Authority	V/13.4.1/272, V/13.4.1/273, X/13.4.1/266